SCHEMBL24422208

SCHEMBL24422208

CC(C)(C)N1CCN(c2ccc(CO)cn2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 3/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.45
▸ AOC3 Q16853 4/20 0.43
▸ PANK3 Q9H999 1/20 0.40
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ ME2 P23368 3/20 0.38
▸ ME1 P48163 3/20 0.38
▸ ME3 Q16798 3/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.38
▸ SORD Q00796 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD1 P21728 1/20 0.37
▸ DRD4 P21917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21934609 0.85 CYP11B1 (0.41) SMOAOC3PANK3CYP11B1CYP11B2
SCHEMBL11988947 0.83 SMO (0.52) SMOHRH3AOC3SMN1; SMN2HTR1A
SCHEMBL3980082 0.82 AOC3 (0.46) SMOAOC3PANK3CYP11B1CYP11B2
SCHEMBL3086082 0.80 AOC3 (0.54) SMOHRH3AOC3JAK2JAK1
SCHEMBL844082 0.80 GAA (0.52) SMOHRH3AOC3CYP11B1CYP11B2
SCHEMBL29562890 0.80 AOC3 (0.47) AOC3PANK3ME2ME1ME3
SCHEMBL24422287 0.80 ME2 (0.52) SMOME2ME1ME3SMN1; SMN2
SCHEMBL987818 0.79 AOC3 (0.55) SMOHRH3AOC3HPGDALDH1A1
SCHEMBL24421697 0.79 HRH3 (0.65) SMOHRH3ALDH1A1MAPT
SCHEMBL19001112 0.78 OGA (0.54) SMOHRH3HPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor MIF, MMP12, SLC11A2 SMO 3225/4885HRH3 2018/4885AOC3 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback